ofloxacin has been researched along with cefazolin in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.33) | 18.7374 |
| 1990's | 14 (32.56) | 18.2507 |
| 2000's | 19 (44.19) | 29.6817 |
| 2010's | 8 (18.60) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gentry, LO; Rodriguez-Gomez, G | 1 |
| Bariffi, F; De Masi, AL; Giacomelli, P; Perna, F; Sanduzzi, A | 1 |
| Alfonso, E; Fink, NE; Maguire, MG; McDonnell, P; O'Brien, TP | 1 |
| Bren, AF; Gucek, A; Hergouth, V; Lindic, J; Mlinsek, D | 1 |
| Kaiser, AB; Kernodle, DS | 1 |
| Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME | 1 |
| Baker, RS; Casey, R; Flowers, CW; Fong, DS; Wilson, MR | 1 |
| Golopykho, LI; Gorshevikova, EV; Nichitaĭlo, ME; Saenko, VF; Viktorov, AP | 1 |
| Schwartz, BF; Swanzy, S; Thrasher, JB | 1 |
| Tuohy, M; Washington, JA | 1 |
| Hamer, KE; Rupp, ME | 1 |
| Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
| Furuya, N; Iwata, M; Matsumoto, T; Mizuiri, S; Tateda, K; Yamaguchi, K | 1 |
| Ahuja, R; Panda, A; Sastry, SS | 1 |
| Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
| Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Riva, A; Saba, V; Scalise, G | 1 |
| Ciftçi, M; Erat, M | 1 |
| Gurkan, T; Oguz, E; Oguz, H; Ozbilge, H | 1 |
| Arnold, FW; Wojda, B | 1 |
| Ahmadi, AH; Cohen, BE; Shayani, P | 1 |
| Anguita-Alonso, P; Jacofsky, DJ; Osmon, DR; Patel, R; Piper, KE; Rouse, MS | 1 |
| Ferraro, SM; Giacomelli, L; Marchese-Ragona, R; Marioni, G; Ottaviano, G; Rinaldi, R; Staffieri, A; Staffieri, C | 1 |
| Akay, T; Ozkan, S | 1 |
| Aradhyula, S; Greisnauer, S; Manian, FA; Meyer, PL; Senkel, D; Setzer, J; Wiechens, M | 1 |
| Constantinou, M; Daniell, M; Snibson, GR; Taylor, HR; Vu, HT | 1 |
| Eisen, L; Kim, J; Rosenberg, J | 1 |
| Kim, SY; Lee, YC; Park, YH | 1 |
| Cliby, WA; Diehl, CL; El-Nashar, SA; Famuyide, AO; Stanhope, CR; Swanson, CL; Thompson, RL | 1 |
| Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Ebisutani, C; Inoue, H; Kinoshita, Y; Nishi, K; Sato, S; Yoshie, T | 1 |
| Feldman, D; Sarabanchong, VO; Treszezamsky, AD | 1 |
| Bian, ZQ; Han, J; Li, Y; Wang, GC; Zhang, YL; Zuo, GY | 1 |
| Rocke, J; Roydhouse, T; Spencer, T | 1 |
| Das, S; Gunasekaran, R; Mitra, S; Mohamed, A; Prajna, L; Prajna, NV; Sharma, S; Soni, T | 1 |
1 review(s) available for ofloxacin and cefazolin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 trial(s) available for ofloxacin and cefazolin
| Article | Year |
|---|---|
Ofloxacin versus parenteral therapy for chronic osteomyelitis.
Topics: Administration, Oral; Adult; Aged; Cefazolin; Ceftazidime; Chronic Disease; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Male; Middle Aged; Ofloxacin; Osteomyelitis; Recurrence | 1991 |
A comparative study of ofloxacin versus cefazolin in lower respiratory tract infections.
Topics: Adult; Aged; Anti-Infective Agents; Cefazolin; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Random Allocation; Respiratory Tract Infections | 1987 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Cornea; Corneal Ulcer; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Tobramycin; Treatment Outcome | 1995 |
Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?
Topics: Adult; Aged; Cefazolin; Female; Humans; Male; Middle Aged; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies | 1994 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 1995 |
A randomized prospective comparison of antibiotic tissue levels in the corpora cavernosa of patients undergoing penile prosthesis implantation using gentamicin plus cefazolin versus an oral fluoroquinolone for prophylaxis.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Follow-Up Studies; Gentamicins; Humans; Male; Ofloxacin; Penile Prosthesis; Penis; Prospective Studies; Prosthesis-Related Infections; Tissue Distribution | 1996 |
Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Staphylococcal Infections; Tobramycin; Visual Acuity | 1999 |
A prospective study of antibiotic efficacy in preventing infection in reduction mammaplasty.
Topics: Adult; Antibiotic Prophylaxis; Cefazolin; Cephalexin; Female; Humans; Mammaplasty; Ofloxacin; Prospective Studies; Single-Blind Method; Surgical Wound Infection; Wound Healing | 2005 |
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Child; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome | 2007 |
Antibiotic prophylaxis in transcatheter treatment of hepatocellular carcinoma: an open randomized prospective study of oral versus intravenous administration.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Carcinoma, Hepatocellular; Cefazolin; Chemoembolization, Therapeutic; Female; Humans; Inflammation Mediators; Infusions, Intra-Arterial; Infusions, Intravenous; Levofloxacin; Liver Neoplasms; Male; Middle Aged; Ofloxacin; Postoperative Complications; Prospective Studies; Treatment Outcome | 2010 |
32 other study(ies) available for ofloxacin and cefazolin
| Article | Year |
|---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection.
Topics: Animals; Cefazolin; Ciprofloxacin; Drug Resistance, Microbial; Female; Guinea Pigs; Male; Ofloxacin; Staphylococcal Infections; Vancomycin; Wound Infection | 1994 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Clinical Trials as Topic; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Tobramycin | 1996 |
[A clinical evaluation of the efficacy of using Zanocin (ofloxacin) in surgery].
Topics: Adult; Anti-Infective Agents; Biliary Fistula; Cefazolin; Cephalosporins; Cholangitis; Drug Evaluation; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Middle Aged; Ofloxacin | 1995 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis.
Topics: Bacterial Adhesion; Biofilms; Catheters, Indwelling; Cefazolin; Isomerism; Ofloxacin; Staphylococcus epidermidis; Vancomycin | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
Primary Shewanella alga septicemia in a patient on hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Drug Therapy, Combination; Escherichia coli; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Renal Dialysis | 1999 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model].
Topics: Animals; Blood Vessel Prosthesis Implantation; Cefazolin; Drug Evaluation, Preclinical; Drug Implants; Drug Resistance; Drug Therapy, Combination; Injections, Intraperitoneal; Levofloxacin; Male; Methicillin Resistance; Models, Animal; Ofloxacin; Oxacillin; Premedication; Prostheses and Implants; Prosthesis-Related Infections; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin | 2001 |
In vitro effects of some antibiotics on glutathione reductase from sheep liver.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Cefepime; Cephalosporins; Gentamicins; Glutathione Reductase; In Vitro Techniques; Levofloxacin; Liver; Ofloxacin; Sheep; Thiamphenicol | 2003 |
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Taurine; Thiadiazines | 2005 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Comparative study of antimicrobial release kinetics from polymethylmethacrylate.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Cefazolin; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Polymethyl Methacrylate; Rifampin | 2006 |
Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cefazolin; Ceftibuten; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nasal Polyps; Ofloxacin; Prospective Studies; Sinusitis; Sulbactam | 2007 |
Diaphragm paralysis in children after cardiac surgery.
Topics: Anti-Bacterial Agents; Cardiac Surgical Procedures; Cefazolin; Diaphragm; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Ofloxacin; Paralysis; Phrenic Nerve; Piperacillin; Pneumonia; Postoperative Complications; Risk Factors; Sepsis | 2007 |
Is it Clostridium difficile infection or something else? A case-control study of 352 hospitalized patients with new-onset diarrhea.
Topics: Aged; Analysis of Variance; Case-Control Studies; Cefazolin; Ceftriaxone; Clostridioides difficile; Confidence Intervals; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Levofloxacin; Male; Missouri; Multivariate Analysis; Odds Ratio; Ofloxacin; Regression Analysis; Retrospective Studies; Risk Factors | 2007 |
Moxifloxacin for bacterial keratitis.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Ofloxacin; Quinolines; Randomized Controlled Trials as Topic; Tobramycin; Treatment Outcome | 2008 |
Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aza Compounds; Cefazolin; Cell Count; Cornea; Endothelium, Corneal; Fluoroquinolones; Injections; Levofloxacin; Microscopy, Electron, Scanning; Moxifloxacin; Ofloxacin; Quinolines; Rabbits | 2008 |
Extended antibiotic prophylaxis for prevention of surgical-site infections in morbidly obese women who undergo combined hysterectomy and medically indicated panniculectomy: a cohort study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Mass Index; Cefazolin; Ciprofloxacin; Cohort Studies; Drainage; Drug Administration Schedule; Female; Humans; Hysterectomy; Middle Aged; Obesity, Morbid; Ofloxacin; Retrospective Studies; Subcutaneous Fat, Abdominal; Surgical Wound Infection | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Concurrent postpartum uterine and abdominal wall dehiscence and Streptococcus anginosus infection.
Topics: Abdominal Wall; Acute Disease; Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Cesarean Section; Chorioamnionitis; Female; Humans; Levofloxacin; Metronidazole; Ofloxacin; Postoperative Complications; Postpartum Period; Pregnancy; Streptococcal Infections; Streptococcus anginosus; Surgical Wound Dehiscence; Uterus; Vasculitis | 2011 |
Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Berberine; Cefazolin; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Synergism; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin | 2012 |
Canaliculitis caused by Citrobacter freundii.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Canaliculitis; Cefazolin; Citrobacter freundii; Combined Modality Therapy; Curettage; Drug Therapy, Combination; Enterobacteriaceae Infections; Eye Infections, Bacterial; Female; Humans; Ofloxacin | 2016 |
Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Coinfection; Corynebacterium; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2022 |